¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"diffusion capacity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffusion time
    È®»ê½Ã°£
  • diffusion weighted imaging
    È®»ê°­Á¶¿µ»ó
  • diffusion-limited transport
    È®»êÁ¦ÇÑ¿î¹Ý
  • facilitated diffusion
    ÃËÁøÈ®»ê, Áß°³È®»ê
  • gel diffusion precipitin reaction
    °ÖÈ®»êħÀü¹ÝÀÀ
  • identity diffusion
    Á¤Ã¼¼ºÈ®»ê
  • passive diffusion
    ¼öµ¿È®»ê
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • radial diffusion
    ºÎê»ìÈ®»ê, ¹æ»çÈ®»ê
  • self diffusion
    ÀÚ°¡È®»ê, ÀÚüȮ»ê
  • simple diffusion
    ´Ü¼øÈ®»ê
  • antigen binding capacity
    Ç׿ø°áÇÕ´É
  • adsorption capacity
    ÈíÂø´É
  • agglutinating capacity
    ÀÀÁý´É
  • bladder capacity
    ¹æ±¤¿ëÀû
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffusion rate
    È®»êÀ²
  • diffusion spectroscopy
    È®»êºÐ±¤¹ý
  • diffusion time
    È®»ê½Ã°£
  • diffusion gradient pulse
    È®»ê°æ»ç¸Æ¹Ú, È®»ê°æ»ç¸Æ¹Ú
  • diffusion tensor imaging
    È®»êÅÙ¼­¿µ»ó
  • diffusion weighted imaging
    È®»ê°­Á¶¿µ»ó
  • diffusion-limited transport
    È®»êÁ¦ÇÑ¿î¹Ý
  • facilitated diffusion
    ÃËÁøÈ®»ê, Áß°³È®»ê, È®»êÃËÁø
  • identity diffusion
    ÁÖü¼ºÈ®»ê
  • passive diffusion
    ¼öµ¿È®»ê
  • radial diffusion
    ºÎê»ìÈ®»ê
  • respiratory diffusion
    È£ÈíÈ®»ê
  • self diffusion
    ÀÚ°¡È®»ê, ÀÚüȮ»ê
  • simple diffusion
    ´Ü¼øÈ®»ê
  • gel diffusion precipitin reaction
    ¿ì¹«È®»êħÀü¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • identity diffusion
    Á¤Ã¼¼º È®»ê
  • Forced expiratory vital capacity
    °­Á¦È£±âÆóȰ·®(Ë­ð¤û¼Ñ¨øËüÀÕá)
  • IBC= iron binding capacity
    ö°áÇÕ´É.
  • MBC=£¾maximum breathing capacity
    ÃÖ´ëÈ£Èí(¿ë)·®, ÃÖ´ëȯ±â·®.
  • TIBC => total iron binding capacity
    ÃÑö°áÇÕ´É
  • TLC => total lung capacity
    ÀüÆó¿ë·®
  • UIBC => unsaturated iron binding capacity
    ºÒÆ÷ȭö°áÇÕ´É
  • VC => vital capacity
    ÆóȰ·®, Æó¸ð¼¼°ü Ç÷¾×·®
  • VC= vital capacity
    ÆóȰ·®, Æó¸ð¼¼°ü Ç÷¾×·®.
  • adsorption capacity
    ÈíÂø´É(ýåó·Òö).
  • agglutinating capacity
    ÀÀÁý´É
  • antigen binding capacity
    Ç׿ø°áÇÕ´É(¡­Ì¿ùêÒö).
  • functional residual capacity =FRC
    ±â´ÉÀû ÀÜ·ù¿ë·®(íÑ×¶éÄÕá), ±â´ÉÀû Àܱⷮ(íÑѨÕá).
  • heat capacity
    ¿­¿ë·®(æðé»åÖ).
  • inspiratory capacity
    Èí½Ä¿ë·®, Èí±â¿ëÀû.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • forced vital capacity =FVC
    °­Á¦ÆóȰ·®,³ë·Â¼º ÆóȰ·®, ³ë¼º ÆóȰ·®
  • forced vital capacity =FVC
    °­Á¦ÆóȰ·®(Ë­ð¤øËüÀÕá), ³ë·Â¼º ÆóȰ·®(Ò½æ³àõøËüÀåÖ), ³ë¼º?
  • forced vital capacity =FVC
    °­Á¦ÆóȰ·®, ³ë·Â¼º ÆóȰ·®(Ò½æ³àõ
  • functional capacity
  • functional residual capacity
  • functional residual capacity =FRC
    ±â´ÉÀû ÀÜ·ù¿ë·®, ±â´ÉÀû Àܱⷮ
  • functional residual capacity =FRC
    ±â´ÉÀû ÀÜ·ù¿ë·®(íÑ×¶éÄÕá), ±â´ÉÀû Àܱⷮ(íÑѨÕá).
  • heat capacity
    ¿­¿ë·®(æðé»åÖ).
  • inspiratory capacity
    Èí½Ä¿ë·®, Èí±â¿ëÀû.
  • inspiratory capacity
    Èí½Ä¿ë·®,Èí±â¿ëÀû
  • inspiratory capacity
    Èí½Ä¿ë·®(ýåãÓé»Õá), Èí±â¿ëÀû(ýåѨé»îÝ) .
  • inspiratory vital capacity
    Èí±âÆóȰ·®.
  • inspiratory vital capacity
    Èí±âÆóȰ·®(ýåѨøËüÀÕá).
  • iron binding capacity =IBC
    ö°áÇÕ´É(ôÑÌ¿ùêÒö).
  • iron-binding capacity
    ö°áÇÕ´É
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffusion potential
    È®»êÀüÀ§(üªß¤ï³êÈ)
  • double diffusion
    ÀÌÁß È®»ê(ì£ñìüªß¤)
  • eddy diffusion
    ¿ÍÈ®»ê(è¾üªß¤)
  • exchange diffusion
    ±³È¯ È®»ê (Îßüµüªß¤)
  • facilitated diffusion
    ÃËÁøÈ®»ê (õµòäüªß¤)
  • film diffusion
    Çʸ§ È®»ê(üªß¤)
  • forced diffusion
    °­Á¦ È®»ê(Ë­ð¤üªß¤)
  • free diffusion
    ÀÚÀ¯ È®»ê(í»ë¦üªß¤)
  • gel diffusion
    Á© È®»ê(üªß¤)
  • lateral diffusion
    Ãø¸éÈ®»ê(ö°Øüüªß¤)
  • main diffusion coefficient
    ÁÖÈ®»ê°è¼ö(ñ«üªß¤Ìõâ¦)
  • particle diffusion
    ÀÔÀÚÈ®»ê(Ø£í­üªß¤)
  • passive diffusion
    ¼öµ¿ È®»ê(áôÔÑüªß¤)
  • restricted diffusion
    Á¦ÇÑ È®»ê(ð¤ùÚüªß¤)
  • restricted diffusion chromatography
    Á¦ÇÑ È®»ê Å©·Î¸¶Åä±×·¡ÇÇ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffusion weighted imaging [=DWI]
    È®»ê°­Á¶¿µ»ó
  • exchange diffusion
    ±³È¯È®»ê
  • heavily diffusion weighted MRI
    ÁßÈ®»ê°­Á¶ÀÚ±â°ø¸í¿µ»ó
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • self diffusion
    ÀÚ°¡È®»ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DC daily census; data communication; data conversion; decrease; deep compartment; Dental Corps; deoxych...
DL danger list; De Lee [catheter]; deep lobe; developmental level; difference limen; diffusion lung [ca...
DLCO carbon monoxide diffusion in the lung; single-breath diffusing capacity
Dsb single-breath diffusion capacity
ANC absolute neutrophil count; acid neutralization capacity; antigen-neutralizing capacity; Army Nurse C...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
Ds diffusion coefficient
DW Diffusion weighted
DWI Diffusion weighted MRI
DWI Diffusion-weighted images
DWI Diffusion weighted magnetic resonance imaging
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • diffusion coefficient
    È®»ê °è¼ö
    Gel ³» È®»ê¹ýÀ» »ç¿ëÇÒ ¶§¿¡ ´Ü¹éÁúÀÇ È®»êÀ²À» Ç¥ÇöÇÏ´Â °è¼ö. ´ëüÀûÀÎ Ç׿øÀÇ ºÐÀÚ·®À» ÃøÁ¤ÇÏ´Â °æ¿ì¿¡ »ç¿ëµÈ´Ù.
  • diffusion factor
    È®»ê ÀÎÀÚ
  • diffusion method
    È®»ê¹ý
  • diffusion rate
    È®»êÀ²
  • double diffusion test
    ÀÌÁß È®»ê ½ÃÇè
  • exchange diffusion
    ±³È¯ È®»ê
  • facilitated diffusion
    ÃËÁø È®»ê, Áß°³ È®»ê
  • heavily diffusion weighted MRI
    ÁßÈ®»ê °­Á¶ Àڱ⠰ø¸í ¿µ»ó
  • law of diffusion
    È®»ê¹ýÄ¢
    ¸ðµç ¹°ÁúÀº °í³óµµ¿¡¼­ Àú³óµµ·Î ¹°ÁúÀÌ À̵¿ÇÑ´Ù.
  • mucosal barrier to acid back-diffusion

    mucosal bleeding (Á¡¸· ÃâÇ÷

  • perfusion and diffusion imaging
    °ü·ù È®»ê ¿µ»ó
  • simple diffusion
    ´Ü¼ø È®»ê, ´Ü¼ø È®»ê¹ý
  • thermal diffusion
    ¿­ È®»ê
    È¥ÇÕ À¯Ã¼ÀÇ ³»ºÎ¿¡ ¿Âµµ ±¸¹è°¡ ÀÖÀ» ¶§ ¼ººÐ¿¡ µû¶ó °¢°¢ °í¿Â Ãø°ú Àú¿Â ÃøÀ¸·Î ¸ð¿© ºÐ¸®µÇ´Â Çö»ó.
  • turbulent diffusion
    ¿Í·ù È®»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
hospital bed capacity The number of beds which a hospital has been designed and constructed to contain. It may also refer to the number of beds set up and staffed for use.
(12 Dec 1998)
specific heat capacity <chemistry> The amount of energy required to raise the temperature of one gram of a substance by one degree Celsius (or Kelvin).
(09 Jan 1998)
diffusing capacity The amount of oxygen taken up by pulmonary capillary blood per minute per unit average oxygen pressure gradient between alveolar gas and pulmonary capillary blood; units are: ml/min/mm Hg; also applied to other gases such as carbon monoxide.
(05 Mar 2000)
inspiratory capacity The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the tidal volume and the inspiratory reserve volume. Common abbreviation is ic.
(12 Dec 1998)
iron-binding capacity The capacity of iron-binding protein in serum (transferrin) to bind serum iron.
(05 Mar 2000)
oxygen capacity The maximum quantity of oxygen that will combine chemically with the haemoglobin in a unit volume of blood; normally it amounts to 1.34 ml of O2 per gm of Hb or 20 ml of O2 per 100 ml of blood.
(05 Mar 2000)
thermal capacity <chemistry> The amount of energy required to raise the temperature of an object by one degree Celsius (or Kelvin), it is represented by the symbol C and is given in units of J/K.
(09 Jan 1998)
total iron binding capacity <biochemistry, haematology> A test that measures indirectly the transferrin level in the bloodstream.
Transferrin is a protein that carries iron in the body. Normal values are 240 to 450 mcg/dl. This test is used to evaluate anaemia. Greater than normal total iron binding capacity can be seen in: iron deficiency anaemia, late pregnancy and polycythaemia vera.
Lower than normal total iron binding capacity can be seen in cirrhosis, sickle cell anaemia, hypoproteinaemia, pernicious anaemia and haemolytic anaemia. The use of birth control pills can lead to increased total iron binding capacity measurements.
Acronym: TIBC
(12 Jan 1998)
total lung capacity The volume of air contained in the lungs at the end of a maximal inspiration. It is the equivalent to each of the following sums: vital capacity plus residual volume; inspiratory capacity plus functional residual capacity; tidal volume plus inspiratory reserve volume plus functional residual capacity; tidal volume plus inspiratory reserve volume plus expiratory reserve volume plus residual volume.
(12 Dec 1998)
forced vital capacity Vital capacity measured with the subject exhaling as rapidly as possible; data relating volume, expiratory flow, and time form the basis for other pulmonary function tests, e.g., flow-volume curve, forced expiratory volume, forced expiratory time, forced expiratory flow.
(05 Mar 2000)
functional residual capacity The volume of air remaining in the lungs at the end of a normal, quiet expiration. It is the sum of the residual volume and the expiratory reserve volume. Common abbreviation is frc.
(12 Dec 1998)
ambipolar diffusion <radiobiology> Diffusion process in which buildup of spatial charge creates electric fields which cause electrons and ions to leave the plasma at the same rate. (Such electric fields are self-generated by the plasma and act to preserve charge neutrality.)
(09 Oct 1997)
anomalous diffusion <radiobiology> Diffusion in most plasma devices, particularly tokamaks, is higher than what one would predict from understood causes. The observed, typical diffusion is referred to as anomalous because it has not yet been explained.
Anomalous diffusion includes all diffusion which is not due to collisions and geometric effects. While such effects were not understood when the term was coined, and most still are not, diffusion due to well-understood wave phenomena is still 'anomalous'. Classical diffusion and Neo-classical diffusion are the two well-understood diffusion theories, although neither is adequate to fully explain the observed anomalous diffusion.
See: entries for classical diffusion and neoclassical diffusion. Anomalous resistivity
(09 Oct 1997)
bohm diffusion <radiobiology> A rapid loss of plasma across magnetic field lines caused by microinstabilities. Theory formulated by the physicist David Bohm.
Semiempirical formula for the diffusion coefficient given by Bohm in 1946 (noted by Bohm, Burhop, and Massey, who were developing a magnetic arc for use in uranium isotope separation). Bohm diffusion was proposed (not derived from first principles) to scale as 1/B rather than the 1/B^2 scaling predicted by classical diffusion. A 1/B scaling results from assuming that particles diffuse across field lines at an optimum rate (effective collision frequency=cyclotron frequency). The 1/B scaling is observed (approximately) in most reactors.
See: diffusion, microinstabilities, field lines.
(09 Oct 1997)
gel diffusion Diffusion in a gel, as in the case of gel diffusion precipitin tests in which the immune reactants diffuse in agar.
See: immunodiffusion.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á